Need for standardization in population-based quality of life studies: A review of the current literature

Inflammatory Bowel Diseases

Volumn 16, Issue 3, 2010, Pages 525-536

  Hoivik, Marte Lie ^a   Bernklev, Tomm ^a   Moum, Bjorn ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Crohn's disease; Health related quality of life; Population based; Standardization; Ulcerous colitis

Indexed keywords

CASE STUDY; COLITIS; COLON CROHN DISEASE; CROHN DISEASE; CROSS-SECTIONAL STUDY; ENTERITIS; HUMAN; INTERVENTION STUDY; MEDICAL RESEARCH; METHODOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROCTITIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SHORT FORM 36; STANDARDIZATION; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; VALIDATION STUDY;

COLITIS, ULCERATIVE; CROHN DISEASE; HEALTH STATUS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77149136801     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21032     Document Type: Review

References (52)

1. Jarnerot G, Lennard-Jones J, Truelove S. Inflammatory Bowel Disease. Malmo, Sweden: Corona/Astra; 1992.
2. Maunder RG, Cohen Z, McLeod RS, et al. Effect of intervention in inflammatory bowel disease on health-related quality of life: a critical review. Dis Colon Rectum. 1995;38:1147-1161.
3. Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut. 2000;47:444-454.
4. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
5. Last JM. A Dictionary of Epidemiology. Oxford: Oxford University Press; 2008.
6. Broering DC, Eisenberger CF, Koch A, et al. Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy. Int J Colorectal Dis. 2001;16:81-87.
7. Munkholm P, Langholz E, Davidsen M, et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol. 1995;30:699-706.
8. Hjortswang H, Strom M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol. 1998;93: 2203-2211.
9. Petrak F, Hardt J, Clement T, et al. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol. 2001;36: 375-382.
10. de Rooy EC, Toner BB, Maunder RG, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001;96:1816-1821.
11. Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterol. 2002;2:1.
12. Casellas F, Lopez-Vivancos J, Casado A, et al. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002;11:775-781.
13. Hjortswang H, Jarnerot G, Curman B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2003;15: 1011-1020.
14. van der Eijk I, Vlachonikolis IG, Munkholm P, et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis. 2004;10:392-398.
15. Janke KH, Raible A, Bauer M, et al. Questions on life satisfaction (FLZM) in inflammatory bowel disease. Int J Colorectal Dis. 2004; 19:343-353.
16. Janke KH, Klump B, Gregor M, et al. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11: 272-286.
17. Casellas F, Arenas JI, Baudet JS, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005;11:488-496.
18. Zutshi M, Hull TL, Hammel J. Crohn's disease: a patient's perspective. Int J Colorectal Dis. 2007;22:1437-1444.
19. Gibson PR, Weston AR, Shann A, et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol. 2007;22:1306-1312.
20. Russel MG, Nieman FH, Bergers JM, et al. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group [see Comment]. Eur J Gastroenterol Hepatol. 1996;8:1075-1081.
21. Nordin K, Pahlman L, Larsson K, et al. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:450-457.
22. Rubin GP, Hungin AP, Chinn DJ, et al. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment Pharmacol Ther. 2004;19:529-535.
23. Bernklev T, Jahnsen J, Aadland E, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004;39:365-373.
24. Bernklev T, Jahnsen J, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis. 2005;11:909-918.
25. Bernklev T, Jahnsen J, Schulz T, et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol. 2005;17:1037-1045.
26. Palm O, Bernklev T, Moum B, et al. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol. 2005;32: 1755-1759.
27. Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12:402-412.
28. Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006;4:1491-1501.
29. Canavan C, Abrams KR, Hawthorne B, et al. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment Pharmacol Ther. 2006;23:377-385.
30. Allison PJ, Locker D, Feine JS. Quality of life: a dynamic construct. Soc Sci Med. 1997;45:221-230.
31. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804-810.
32. Cheung WY, Garratt AM, Russell IT, et al. The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. Development and validation. J Clin Epidemiol. 2000;53:297-306.
33. Lopez-Vivancos J, Casellas F, Badia X, et al. Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion. 1999;60:274-280.
34. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571-1578.
35. Bernklev T, Moum B, Moum T, et al. Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scand J Gastroenterol. 2002;37:1164-1174.
36. Drossman DA, Leserman J, Li ZM, et al. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991;53:701-712.
37. Drossman DA, Patrick DL, Mitchell CM, et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379-1386.
38. Pallis AG, Mouzas IA. Instruments for quality of life assessment in patients with inflammatory bowel disease [see Comment]. Dig Liver Dis. 2000;32:682-688.
39. Ware JE, Snow K, Kosinski M, et al. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, New England Medical Center; 1993.
40. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998;51:903-912.
41. Ware JE, Kosinski M, Keller S. SF-36 physical and mental health summary scales: a user's manual. The Health Institute, New England Medical Center; 1994.
42. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
43. Russel MG, Brandon S, Engels LG, et al. Validation of the Dutch translation of the "Inflammatory Bowel Disease Questionnaire."1995.
44. Sullivan MKJ, Ware J. SF-36 Health Survey. Swedish manual and interpretation guide. Gøteborg, Sweden: Sahlgrenska University Hospital; 1994.
45. Loge JH, Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med. 1998; 26:250-258.
46. Loge JH, Kaasa S, Hjermstad MJ, et al. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol. 1998;51:1069-1076.
47. Hopman WM, Towheed T, Anastassiades T, et al. Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group [see Comment]. CMAJ Can Med Assoc J. 2000;163:265-271.
48. Odes S, Vardi H, Friger M, et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology. 2006;131:719-728 [Erratum Gastroenterology 2006;131:2029].
49. Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543-550.
50. Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;21:499-508.
51. Han SW, McColl E, Barton JR, et al. Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations. Inflamm Bowel Dis. 2005;11:24-34.
52. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132: 763-786.